MBX

MBX Biosciences is a drug development company working on treatments for hormonal and metabolic disorders. The company is testing peptide-based drugs, which are made from chains of amino acids. Its main candidate is a therapy for hypoparathyroidism, a condition where the body does not produce enough parathyroid hormone, and another is being studied for low blood sugar that occurs after weight loss surgery. The company is also developing a potential obesity treatment and was founded in 2018.